donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Medical Disorders
Resources
Basic InformationLookupsLatest News
Pfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenDeadly Liver Disease Tied to Obesity Is on the RiseCDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match ShotsMoving Monoclonal Antibody Treatments for COVID From Hospital to HomeConfusion, Seizures: People Hospitalized After Taking Veterinary Drug for COVIDMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyPfizer Vaccine Booster Restores Nearly Full Protection, Company SaysTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseSex of Fetus May Matter When COVID Strikes in PregnancyU.S. Has Shared 200 Million Shots With Other CountriesSalmonella Outbreak in 37 States Linked to Imported OnionsFDA Approves Moderna, J&J Booster Shots, Backs Mix n' Match VaccinesWhite House Announces COVID Vaccination Plan for Young KidsEven With Mild COVID, Obesity May Mean Worse SymptomsNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsFlu Cases Already Up 23% This Season: WalgreensDoctors Report That Kidney Grown in Pig Worked in a HumanHeartburn Meds Might Be Good for Your GumsOne Big Factor for Survival After Spinal Cord Injury: ResilienceDying Young From Heart Disease: Where You Live in the U.S. MattersFDA Expected to Allow Mix n' Match COVID VaccinesPowell's COVID Death Despite Vaccination Shows Danger to Those With Weakened Immune SystemsAHA News: Your Next Doctor's Prescription Might Be to Spend Time in NatureOut-of-Pocket Medical Bills for COVID-19 May Average $3,800 in 2021: StudyLegionnaires' Disease Outbreak Hits Long Island, N.Y.State Lotteries Didn't Help Boost Vaccination RatesFDA Panel Recommends Approval of Johnson & Johnson Booster ShotHeart Defibs in Schools Are Saving Staff Lives: StudyHorseback Riding Carries Big Risk for Serious Injury: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollAnother Study Finds Pfizer, Moderna Shots Effective Against COVID VariantsLyme Disease Often Spotted at Later Stage in Black PatientsFDA Panel Supports Moderna Booster Shot for Older Adults, People at High RiskIs a Really Bad Flu Season on the Way?Climate Change Could Bring Rising Obesity RatesKids Can Carry High, Infectious Levels of COVID CoronavirusMore Than Half of COVID-19 Survivors Will Get 'Long COVID'One-Third of Americans With Arthritis Get No ExerciseDeath Threats, Trolling Common for Scientists Who Speak to Media About COVIDAHA News: The Differences and Similarities Between the Flu and COVID-19FDA Questions Strength of Johnson & Johnson's Booster Shot DataHelmets Can Saves Lives in ATV, Dirt Bike CrashesCancer Care Costs U.S. $156 Billion Per Year; Drugs a Major FactorFDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster ShotsAnti-Nausea Drug May Boost Survival for Some Cancer PatientsExpert Panel Backs Off Recommendation for Aspirin to Prevent Heart TroubleAccess to Top Drugs Makes the Difference for Black Lung Cancer PatientsRisk of COVID from Grocery Store Surfaces Very Low: Study60% of Americans Will Delay or Skip Flu Shot This Year: Survey
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

CDC Expert Panel to Weigh In on Vaccine Boosters

HealthDay News
by Robin Foster and Steven Reinberg
Updated: Sep 22nd 2021

new article illustration

WEDNESDAY, Sept. 22, 2021 (HealthDay News) -- An advisory panel to the U.S. Centers for Disease Control and Prevention will meet on Wednesday to discuss which Americans, if any, should get Pfizer booster shots to rev up their immunity to COVID-19.

Their recommendation will follow a decision by a U.S. Food and Drug Administration expert panel to only give booster shots to those over 65 and those in high-risk groups.

The CDC panel will deliberate which high-risk groups should get a booster shot. The decision could come as late as Thursday, The New York Times reported.

The Biden administration had said that it planned to start offering booster shots to most vaccinated adults this week, pending approval from federal agencies.

Scientists from Pfizer and the Israeli Ministry of Health presented data to the FDA panel on Friday showing that immunity given by the vaccine fades over time, but a third shot boosts immunity and could have the same effect in the United States.

But one critical difference is that the two countries have had different experiences with the vaccine: In Israel, anyone with an accelerated respiratory rate and an oxygen level of below 94% is considered severely ill. However, the CDC defines that category as people who are sick enough to be hospitalized, said Dr. Sara Oliver, a CDC scientist who presented the American data, the Times reported.

Some committee members said they also did not feel comfortable offering booster shots to young people who may not need them, when the risks of a third dose are unknown. The vaccines have been tied to rare cases of heart inflammation in younger people. Still, the risk is small and research has shown that COVID-19 is much more likely to cause the condition.

In the end, the FDA panel concluded the two-shot regimen was sufficient for most people in preventing severe illness and hospitalization.

"It's unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease," Dr. Michael Kurilla, a committee member and an official at the U.S. National Institutes of Health, told the Times.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on COVID vaccines.


SOURCE: The New York Times